Esa Medika Mandiri Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Esa Medika Mandiri Tbk. trades at Rp358 (market cap 620.46B, 8.41M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Esa Medika Mandiri Tbk. and UBC Medical Indonesia Tbk. are close in size by market cap, and Esa Medika Mandiri Tbk. is more actively traded (8.41M versus 843K). Which is the better fit depends on your goals.
| EMMI | LABS | |
|---|---|---|
Market Cap | 620.46B | 635.95B |
Volume | 8.41M | 843K |
Lot | 84.09K | 8.43K |
Turnover | 2.92B | 137.6M |
Average Price | 347.69 | 163.22 |
Value | 2.92B | 137.6M |
Indicative Equilibrium Price | 358 | 165 |
Indicative Equilibrium Volume | 3.01K | 246 |
Trailing returns across standard periods
Latest headlines on both assets
PT Esa Medika Mandiri Tbk (the Company) was established in the Republic of Indonesia based on Notarial Deed No. 1 of Tuti Setiahati K Soetoro SH dated January, 26 2000. The Company commenced commercial operations in 2000.
Read more on EMMI →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →